These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38798256)

  • 1. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
    Yang Y; Huang F; Wu X; Huang C; Li Y
    Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 4. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
    Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
    Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
    Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
    Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
    Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
    J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV-induced DNA methyltransferase 1 promotes hypermethylation of tissue inhibitor of metalloproteinase 2 in the human skin.
    Kim HY; Lee DH; Shin MH; Shin HS; Kim MK; Chung JH
    J Dermatol Sci; 2018 Jul; 91(1):19-27. PubMed ID: 29685765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
    Zhang Z; Wang J; Wang X; Song W; Shi Y; Zhang L
    Arch Gynecol Obstet; 2018 Feb; 297(2):433-442. PubMed ID: 29177591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
    Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
    Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.
    Tofrizal A; Fujiwara K; Azuma M; Kikuchi M; Jindatip D; Yashiro T; Yamada S
    Med Mol Morphol; 2017 Sep; 50(3):145-154. PubMed ID: 28353090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
    Shin YJ; Kim JH
    PLoS One; 2012; 7(1):e30393. PubMed ID: 22272343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion.
    Shi L; Zhang Q; Zhu S; Tang Q; Chen X; Lan R; Wang N; Zhu Y
    Mol Cell Biochem; 2024 Apr; 479(4):831-841. PubMed ID: 37199893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
    Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
    Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of runt-related transcription factor 3 gene expression and biologic behavior of esophageal carcinoma TE-1 cells after 5-azacytidine intervention.
    Wang S; Liu H; Akhtar J; Chen HX; Wang Z
    Asian Pac J Cancer Prev; 2013; 14(9):5427-33. PubMed ID: 24175838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EVI1 promotes metastasis by downregulating TIMP2 in metastatic colon and breast cancer cells.
    Pradeepa ; Suresh V; Singh VK; Nayak KB; Senapati S; Chakraborty S
    Int J Biochem Cell Biol; 2022 Jan; 142():106118. PubMed ID: 34800694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA-mediated silencing of bFGF gene inhibits the proliferation, migration, and invasion of human pituitary adenoma cells.
    Zhou K; Fan YD; Duysenbi S; Wu PF; Feng ZH; Qian Z; Zhang TR
    Tumour Biol; 2017 Jun; 39(6):1010428317704805. PubMed ID: 28656882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
    Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
    Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
    Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
    Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.